Clinical Trial Update: Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy [NA]

View source ↗

Summary

A completed clinical trial evaluated modified photodynamic therapy for central serous chorioretinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinopathy

Drugs mentioned

• Verteporfin (Visudyne) (verteporfin)

Snippet

Sponsor: Shin Kong Wu Ho-Su Memorial Hospital | Conditions: Central Serous Chorioretinopathy | NA | Status: COMPLETED